DST Diagnostische Systeme & Technologien

Loading...

About DST Diagnostische Systeme & Technologien

DST GmbH develops, manufactures and markets innovative in-vitro diagnostics. The product portfolio includes different test systems for laboratory use as well as for point-of-care. Over 600 high quality allergens, produced and characterized in-house, form the basis for professional allergy diagnostics. Semi- and fully automatic test systems enable laboratories to detect human antibodies in serum or plasma samples by use of allergen-coated microtiter plates or strips. The rapid tests allow medical professionals to test their patients at the point-of-care immediately and reliably with just a few drops of capillary blood. DST is certified according to ISO 13485. Stringent quality measures ensure that customers always receive reliable and precise in-vitro diagnostic solutions. With an international distribution network of capable and professional partners, DST's range of high-quality products and services are available worldwide.

Facts about DST Diagnostische Systeme & Technologien
  • Focus : Manufacturer
  • Industry : Diagnostics

Product portfolio of DST Diagnostische Systeme & Technologien

Here you will find DST Diagnostische Systeme & Technologien GmbH

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

View topic world
Topic world Diagnostics

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.